Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer.

Integration Core

Authors Hansoo Park, Sung-Yup Cho, Hyerim Kim, Deukchae Na, Jee Yun Han, Jeesoo Chae, Changho Park, Ok-Kyoung Park, Seoyeon Min, Jinjoo Kang, Boram Choi, Jimin Min, Jee Young Kwon, Yun-Suhk Suh, Seong-Ho Kong, Hyuk-Joon Lee, Edison T. Liu, Jong-Il Kim, Sunghoon Kim, Han-Kwang Yang, Charles Lee
Journal Proceedings of the National Academy of Sciences of the United States of America
Vol.(no.) 112(40)
Pages 12492-12497
Year 20151006
DOI http://10.1073/pnas.1507491112
Attach 20151006_PNAS_112(40)_12492-12497.pdf

.

Related Post

An article about Drug repositioning utilizing Phar...
views 190
The article about Drug repositioning using the medicine data based PharmDB, which is built by Biocon, i-Pharm, and KOBIC got an approval to be publish...
A new targeting drug got published in Nature.
views 152
Halofuginone was used in a clinical trial for cancer and fibrotic diseases.  It was found to bind to tRNA and it targets the active site of ...
Can open-source R&D reinvigorate drug researc...
views 159
아래 첨부파일을 다운로드 하시기 바랍니다.
0 Comments

Leave a reply

Your email address will not be published. Required fields are marked *

*

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

©2010-2017 Medicinal Bioconvergence Research Center. All rights reserved.

Log in with your credentials

Forgot your details?

Skip to toolbar